Is the CD4/CD8 Ratio an Effective Indicator for Clinical Estimation of Adoptive Immunotherapy for Cancer Treatment?

Journal of Cancer Therapy
doi 10.4236/jct.2013.48164
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Adoptive Immunotherapy of Cancer Using CD4+ T Cells

Current Opinion in Immunology
AllergyImmunology
2009English

Antigen-Specific Culture of Memory-Like CD8 T Cells for Adoptive Immunotherapy

Cancer immunology research
Cancer ResearchImmunology
2014English

ErbB2/HER2-specific NK Cells for Adoptive Cancer Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology

Immunity
Infectious DiseasesAllergyImmunology
2013English

Induction of CD4+ and CD8+ T-Cell Responses to the Human Stromal Antigen, Fibroblast Activation Protein: Implication for Cancer Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2005English

Cumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical Trials

Statistics in Biosciences
BiochemistryStatisticsGeneticsProbabilityMolecular Biology
2013English

Diagnostic Performance of Bronchoalveolar Lavage Fluid CD4/CD8 Ratio for Sarcoidosis: A Meta-Analysis

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

A Possible Role of Activated Macrophages in the Adoptive Immunotherapy Using CD4+ T Lymphocytes.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1992English

Recent Advances in Adoptive Cancer Immunotherapy in China

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy